Boris Sepesi

12.9k citations
187 papers · 3.7k indexed · 2 hit papers · h-index 33
Topics
Lung Cancer Diagnosis and Treatment (63 papers)Lung Cancer Treatments and Mutations (57 papers)Cancer Immunotherapy and Biomarkers (45 papers)

In The Last Decade

Boris Sepesi

173 papers receiving 3.6k citations

Hit Papers

Neoadjuvant Chemoimmunotherapy for NSCLC202320262024202520242023255075

Peers

Boris Sepesi
Comparison fields: 5 of 107
  • Pulmonary and Respiratory Medicine 2.3k
  • Oncology 1.4k
  • Surgery 1.3k
  • Radiology, Nuclear Medicine and Imaging 522
  • Immunology 352
Replace Yoshifumi Shimada with:
Yoshifumi Shimada Japan
Nobuyuki Katakami Japan
Yojiro Hashiguchi Japan
Takahiro Tsushima Japan
Masaki Ohi Japan
Tatsuyuki Kawano Japan
Wilson J. Angerson United Kingdom
Hirohisa Kitagawa Japan
Peng Gao China
Theodore Karrison United States
Boris Sepesi relative to Yoshifumi Shimada Japan Yoshifumi Shimada's profile →
Citations per field
00.5×4.8×
Yoshifumi Shimada · 1×
Citations per year

Countries citing papers authored by Boris Sepesi

Since Specialization
Citations

This map shows the geographic impact of Boris Sepesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Sepesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Sepesi more than expected).

Fields of papers citing papers by Boris Sepesi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Sepesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Sepesi. The network helps show where Boris Sepesi may publish in the future.

Co-authorship network of co-authors of Boris Sepesi

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Sepesi. A scholar is included among the top collaborators of Boris Sepesi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Sepesi. Boris Sepesi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 0
5
LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLCbreakdown →
67
6 2
7 24
8 32
9 1
10 0
11 13
12 4
13 7
14 0
15 251
16 15
17 7
18 42
19 58
20 103

About Boris Sepesi

Boris Sepesi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 187 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (63 papers), Lung Cancer Treatments and Mutations (57 papers) and Cancer Immunotherapy and Biomarkers (45 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.3k citations), Oncology (1.4k citations) and Surgery (1.3k citations). Boris Sepesi has collaborated with scholars based in United States, Canada and Brazil. Frequent co-authors include Stephen G. Swisher, Ara A. Vaporciyan, Wayne L. Hofstetter, David C. Rice, Reza J. Mehran, Mara B. Antonoff, Arlene M. Correa, Garrett L. Walsh, Jack A. Roth and John V. Heymach. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026